A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol.
Emily BrownMoon M WiltonVictoria S SprungJoanne A HarroldJason C G HalfordAndrej StancakMalcolm BurgessElaine HowarthA Margot UmplebyGraham J KempJohn Ph WildingDaniel J CuthbertsonPublished in: BMJ open (2021)
ISRCTN 52028580; EUDRACT number 2015-005242-60.